芳香化酶抑制剂-话题@MedSci

#芳香化酶抑制剂#

15篇内容 | 1109人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1360819, encodeId=db03136081908, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=Lancet Oncol：氟维司群联合Capivasertib治疗芳香化酶抑制剂耐药性晚期/复发性ER+HER2-乳腺癌, objectType=article, longId=729208, objectId=e8d9e29208b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8d9e29208b5, replyNumber=0, likeNumber=31, createdTime=2022-06-14, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8d9e29208b5, moduleTitle=Lancet Oncol：氟维司群联合Capivasertib治疗芳香化酶抑制剂耐药性晚期/复发性ER+HER2-乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e8d9e29208b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360818, encodeId=16dd1360818a3, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=ASCO 2022 | FAKTION临床：capivasertib+氟维司群，改善芳香化酶抑制剂耐药MBC患者生存！, objectType=article, longId=729099, objectId=c01ae29099c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c01ae29099c1, replyNumber=0, likeNumber=49, createdTime=2022-06-12, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c01ae29099c1, moduleTitle=ASCO 2022 | FAKTION临床：capivasertib+氟维司群，改善芳香化酶抑制剂耐药MBC患者生存！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c01ae29099c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360817, encodeId=0198136081e0e, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=Clin Cancer Res：mTOR抑制剂sapanisertib联合氟维司群治疗芳香化酶抑制剂进展后ER+/ HER2-的绝经后女性晚期乳腺癌患者的疗效, objectType=article, longId=293538, objectId=db002935384a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=db002935384a, replyNumber=0, likeNumber=45, createdTime=2022-01-08, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db002935384a, moduleTitle=Clin Cancer Res：mTOR抑制剂sapanisertib联合氟维司群治疗芳香化酶抑制剂进展后ER+/ HER2-的绝经后女性晚期乳腺癌患者的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=db002935384a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360816, encodeId=547e1360816bc, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=NEJM：绝经后乳腺癌患者采用芳香化酶抑制剂辅助治疗时间多长为宜？, objectType=article, longId=215029, objectId=5a0c215029ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a0c215029ad, replyNumber=0, likeNumber=35, createdTime=2021-07-31, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a0c215029ad, moduleTitle=NEJM：绝经后乳腺癌患者采用芳香化酶抑制剂辅助治疗时间多长为宜？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a0c215029ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360815, encodeId=e9841360815d0, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=Ann Oncol：3期| 帕博西尼+内分泌治疗 vs 化疗用于ER+HER2-芳香化酶抑制剂耐药的转移性乳腺癌, objectType=article, longId=205891, objectId=075d205891cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=075d205891cb, replyNumber=0, likeNumber=39, createdTime=2021-01-21, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=075d205891cb, moduleTitle=Ann Oncol：3期| 帕博西尼+内分泌治疗 vs 化疗用于ER+HER2-芳香化酶抑制剂耐药的转移性乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=075d205891cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360814, encodeId=064e13608144c, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=Circulation：芳香化酶抑制剂显著增加乳腺癌患者心血管事件风险！, objectType=article, longId=188734, objectId=36d7188e3403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=36d7188e3403, replyNumber=0, likeNumber=43, createdTime=2020-02-26, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=36d7188e3403, moduleTitle=Circulation：芳香化酶抑制剂显著增加乳腺癌患者心血管事件风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=36d7188e3403)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360813, encodeId=e13d1360813f6, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=Ann Oncol：绝经后乳腺癌女性：芳香化酶抑制剂增加结直肠癌风险？, objectType=article, longId=136646, objectId=585f136646c6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=585f136646c6, replyNumber=0, likeNumber=41, createdTime=2018-04-29, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=585f136646c6, moduleTitle=Ann Oncol：绝经后乳腺癌女性：芳香化酶抑制剂增加结直肠癌风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=585f136646c6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360812, encodeId=986e136081283, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=Lancet Oncol：他莫昔芬辅助芳香化酶抑制剂治疗内分泌敏感乳腺癌的疗效如何？, objectType=article, longId=133550, objectId=adbe13355087, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adbe13355087, replyNumber=0, likeNumber=30, createdTime=2018-03-28, rootId=0, userName=仁心济世, userId=fa4716, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adbe13355087, moduleTitle=Lancet Oncol：他莫昔芬辅助芳香化酶抑制剂治疗内分泌敏感乳腺癌的疗效如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adbe13355087)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360811, encodeId=44061360811a5, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=Lancet oncol：芳香化酶抑制剂治疗乳腺癌的更佳时间，以及三种芳香化酶抑制剂的疗效对比, objectType=article, longId=130513, objectId=6f3e13051390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f3e13051390, replyNumber=0, likeNumber=44, createdTime=2018-02-26, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f3e13051390, moduleTitle=Lancet oncol：芳香化酶抑制剂治疗乳腺癌的更佳时间，以及三种芳香化酶抑制剂的疗效对比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f3e13051390)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360810, encodeId=48ab136081081, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=针灸疗法对缓解癌症患者因芳香化酶抑制剂治疗引起的关节炎样疼痛有效, objectType=article, longId=123750, objectId=123c123e5064, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=123c123e5064, replyNumber=0, likeNumber=47, createdTime=2017-12-19, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=123c123e5064, moduleTitle=针灸疗法对缓解癌症患者因芳香化酶抑制剂治疗引起的关节炎样疼痛有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=123c123e5064)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360809, encodeId=fd7213608093d, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=JCO：度洛西汀治疗早期乳腺癌患者芳香化酶抑制剂治疗所致的关节痛效果如何？, objectType=article, longId=120258, objectId=ba831202588c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba831202588c, replyNumber=0, likeNumber=42, createdTime=2017-11-17, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba831202588c, moduleTitle=JCO：度洛西汀治疗早期乳腺癌患者芳香化酶抑制剂治疗所致的关节痛效果如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba831202588c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360808, encodeId=c93a1360808a5, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=JCEM：芳香化酶抑制剂可降低健康男性的胰岛素敏感性, objectType=article, longId=65661, objectId=60a465661b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60a465661b3, replyNumber=0, likeNumber=34, createdTime=2016-03-30, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60a465661b3, moduleTitle=JCEM：芳香化酶抑制剂可降低健康男性的胰岛素敏感性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60a465661b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360807, encodeId=c834136080e6e, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=Lancet：早期乳腺癌内分泌治疗——芳香化酶抑制剂 vs 他莫昔芬（Meta）, objectType=article, longId=57413, objectId=fad55e413b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fad55e413b8, replyNumber=0, likeNumber=50, createdTime=2015-10-20, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fad55e413b8, moduleTitle=Lancet：早期乳腺癌内分泌治疗——芳香化酶抑制剂 vs 他莫昔芬（Meta）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fad55e413b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360806, encodeId=2c121360806bc, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=Lancet：芳香化酶抑制剂 vs 他莫昔芬治疗早期乳腺癌, objectType=article, longId=53781, objectId=62fe53e8116, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=62fe53e8116, replyNumber=0, likeNumber=36, createdTime=2015-07-26, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=62fe53e8116, moduleTitle=Lancet：芳香化酶抑制剂 vs 他莫昔芬治疗早期乳腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=62fe53e8116)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1360805, encodeId=fcae1360805a8, content=<a href='/topic/show?id=14dd869559e' target=_blank style='color:#2F92EE;'>#芳香化酶抑制剂#</a>, objectTitle=Nature：全基因组分析芳香化酶抑制剂治疗乳腺癌的疗效差异, objectType=article, longId=7022, objectId=eea1e02251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eea1e02251, replyNumber=0, likeNumber=37, createdTime=2012-06-14, rootId=0, userName=yaanren, userId=102a153, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eea1e02251, moduleTitle=Nature：全基因组分析芳香化酶抑制剂治疗乳腺癌的疗效差异, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eea1e02251)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

芳香化酶抑制剂

2020-05-29

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

Lancet Oncol：氟维司群联合Capivasertib治疗芳香化酶抑制剂耐药性晚期/复发性ER+HER2-乳腺癌

2022-06-14

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

ASCO 2022 | FAKTION临床：capivasertib+氟维司群，改善芳香化酶抑制剂耐药MBC患者生存！

2022-06-12

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

Clin Cancer Res：mTOR抑制剂sapanisertib联合氟维司群治疗芳香化酶抑制剂进展后ER+/ HER2-的绝经后女性晚期乳腺癌患者的疗效

2022-01-08

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

NEJM：绝经后乳腺癌患者采用芳香化酶抑制剂辅助治疗时间多长为宜？

2021-07-31

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

Ann Oncol：3期| 帕博西尼+内分泌治疗 vs 化疗用于ER+HER2-芳香化酶抑制剂耐药的转移性乳腺癌

2021-01-21

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

Circulation：芳香化酶抑制剂显著增加乳腺癌患者心血管事件风险！

2020-02-26

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

Ann Oncol：绝经后乳腺癌女性：芳香化酶抑制剂增加结直肠癌风险？

2018-04-29

仁心济世 (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

Lancet Oncol：他莫昔芬辅助芳香化酶抑制剂治疗内分泌敏感乳腺癌的疗效如何？

2018-03-28

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

Lancet oncol：芳香化酶抑制剂治疗乳腺癌的更佳时间，以及三种芳香化酶抑制剂的疗效对比

2018-02-26

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

针灸疗法对缓解癌症患者因芳香化酶抑制剂治疗引起的关节炎样疼痛有效

2017-12-19

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

JCO：度洛西汀治疗早期乳腺癌患者芳香化酶抑制剂治疗所致的关节痛效果如何？

2017-11-17

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

JCEM：芳香化酶抑制剂可降低健康男性的胰岛素敏感性

2016-03-30

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

Lancet：早期乳腺癌内分泌治疗——芳香化酶抑制剂 vs 他莫昔芬（Meta）

2015-10-20

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

Lancet：芳香化酶抑制剂 vs 他莫昔芬治疗早期乳腺癌

2015-07-26

yaanren (审核中...)

前往app查看评论内容

#芳香化酶抑制剂#

Nature：全基因组分析芳香化酶抑制剂治疗乳腺癌的疗效差异

2012-06-14

科室
- - 订阅+
  - 更多科室
工具
服务